Topic

Articles

The $8-billion acquisition will broaden Lilly's oncology portfolio in precision medicines and treatments that target cancers caused by specific gene abnormalities.

Lilly to Acquire Loxo Oncology

The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.

Cambrex Acquires Avista Pharma

Merger cites combined strengths in oncology, immunology and inflammation, and cardiovascular disease.

Bristol-Myers Squibb to Acquire Celgene in $74-Billion Deal

The $2.1-billion acquisition strengthens Novartis’ position in nuclear medicine and radioligand therapy for treating cancer.

Novartis Acquires Endocyte

The proposed $12.7-billion deal includes the spinoff of GSK and Pfizer consumer brands to a new UK-listed company. 

GSK and Pfizer Merge Consumer Healthcare Businesses

Roquette has announced the completion of its acquisition of a majority stake in a pharma packaging company based in India.

Roquette Completes Acquisition of Indian Pharma Packaging Company

Capital Recovery Group, Federal Equipment Company, Heritage Global Partners, and PPL Group purchased a 110-acre campus with a flexible pharmaceutical manufacturing and packaging facility from a generics manufacturer in Huntsville, AL.

Investor Group Purchases Multi-Purpose Pharmaceutical Campus in Alabama

The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets. 

Histo-Scientific Research Laboratories and Vet Path Services Merge

The $62-billion acquisition of Shire by Takeda Pharmaceutical was approved by both sets of shareholders.

Takeda, Shire Shareholders Approve Proposed Acquisition

GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.

Mergers and Acquisitions